HK1043546A1 - Cardiovascular and bone treatment using isoflavones - Google Patents

Cardiovascular and bone treatment using isoflavones

Info

Publication number
HK1043546A1
HK1043546A1 HK02105303.9A HK02105303A HK1043546A1 HK 1043546 A1 HK1043546 A1 HK 1043546A1 HK 02105303 A HK02105303 A HK 02105303A HK 1043546 A1 HK1043546 A1 HK 1043546A1
Authority
HK
Hong Kong
Prior art keywords
isoflavones
cardiovascular
bone treatment
bone
treatment
Prior art date
Application number
HK02105303.9A
Other languages
Chinese (zh)
Inventor
Edmund Kelly Graham
James Husband Alan
Original Assignee
諾沃根研究股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 諾沃根研究股份有限公司 filed Critical 諾沃根研究股份有限公司
Publication of HK1043546A1 publication Critical patent/HK1043546A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK02105303.9A 1999-04-28 2002-07-17 Cardiovascular and bone treatment using isoflavones HK1043546A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0083A AUPQ008399A0 (en) 1999-04-28 1999-04-28 Cariovascular applications
PCT/AU2000/000384 WO2000064438A1 (en) 1999-04-28 2000-04-27 Cardiovascular and bone treatment using isoflavones

Publications (1)

Publication Number Publication Date
HK1043546A1 true HK1043546A1 (en) 2002-09-20

Family

ID=3814286

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105303.9A HK1043546A1 (en) 1999-04-28 2002-07-17 Cardiovascular and bone treatment using isoflavones

Country Status (7)

Country Link
EP (1) EP1173165A4 (en)
JP (1) JP2002542286A (en)
AU (1) AUPQ008399A0 (en)
CA (1) CA2370553A1 (en)
HK (1) HK1043546A1 (en)
NZ (1) NZ513328A (en)
WO (1) WO2000064438A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ008299A0 (en) 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
EP1368024A4 (en) * 2001-03-16 2009-03-18 Novogen Res Pty Ltd Treatment of restenosis
AU2008200518B2 (en) * 2001-03-16 2010-04-01 Novogen Research Pty Ltd Treatment of restenosis
JP5060691B2 (en) * 2001-07-09 2012-10-31 雪印メグミルク株式会社 Nutritional composition
DE10151363A1 (en) * 2001-10-17 2003-05-08 Schering Ag Use of estrogen receptor beta agonists to prepare medicaments for producing somatotropic and organotropic effects on the CNS, circulatory, skeletal and immune system in aging men and women
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
JP5384777B2 (en) * 2001-12-18 2014-01-08 有限会社大長企画 Strong muscle agent, anti-inflammatory agent
CA2539029C (en) 2003-09-19 2011-05-03 Sunstar Inc. Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
JP2009536610A (en) * 2006-02-28 2009-10-15 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ Pharmaceutical composition for the prevention / treatment of bone disease and preparation method thereof
PL1988891T3 (en) * 2006-02-28 2017-05-31 Nestec S.A. Compositions and methods for inducing bone growth and inhibiting bone loss
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
WO2008016768A1 (en) * 2006-08-02 2008-02-07 Roberta Diaz Brinton Phytoestrogenic formulations and uses thereof
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
WO2008146835A1 (en) * 2007-05-28 2008-12-04 Fuji Oil Company, Limited Composition for promoting equol production in the blood of subject unable to produce equol
WO2013050930A1 (en) * 2011-10-02 2013-04-11 Sinoveda Canada, Inc, Development of a red clover phytoestrogen product for the prevention or treatment of osteoporosis
US9333192B2 (en) 2010-02-15 2016-05-10 Sinoveda Canada, Inc Phytoestrogen product of red clover and pharmaceutical uses thereof
RU2552300C2 (en) * 2013-10-23 2015-06-10 Государственное бюджетное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Минздрава Российской Федерации Method for correcting bone tissue status and preventing fractures in cardiovascular patients
JP6781427B2 (en) * 2016-05-24 2020-11-04 学校法人日本大学 Tooth relapse inhibitor containing daidzein as an active ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656786B2 (en) * 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
JPH10114653A (en) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk Composition for promoting osteogenesis and preventing bone salt mass from reducing
DE19650777A1 (en) * 1996-12-06 1998-06-10 Meto International Gmbh Method and device for producing deactivatable security elements
EP0979074A4 (en) * 1997-05-01 2003-07-09 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover

Also Published As

Publication number Publication date
AUPQ008399A0 (en) 1999-05-27
EP1173165A4 (en) 2004-05-12
WO2000064438A1 (en) 2000-11-02
CA2370553A1 (en) 2000-11-02
EP1173165A1 (en) 2002-01-23
JP2002542286A (en) 2002-12-10
NZ513328A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
EP1217963A4 (en) Devices and methods for treating tissue
HK1043546A1 (en) Cardiovascular and bone treatment using isoflavones
HK1027986A1 (en) Method of sterilization
GB0110288D0 (en) Composition and treatment method
GB9920785D0 (en) Bone splint
HK1047250A1 (en) Tissue augmentation material and methods
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
GB9919482D0 (en) Waste treatment apparatus and methods
GB2361644B (en) Waste treatment apparatus and methods
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
EP1027007A4 (en) Dental treatment methods
GB2370777B (en) Biodegradable tissue scafold and bone template
PL349786A1 (en) Bone stimulating factor
EP1194439A4 (en) Human eag2
IL133038A0 (en) Novel diagnosis and treatment for atherosclerosis
AU2638002A (en) Tissue treatment
GB9908993D0 (en) Treatment
GB9906710D0 (en) Game and apparatus
PL109436U1 (en) Therapeutic and rehabilitation table
GB9904918D0 (en) Skin treatment
GB9907649D0 (en) Skin treatment
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
TW371983U (en) Bone cabinet of fast and easy combination